CN1293990A - Medicine 'Changlongdan' - Google Patents

Medicine 'Changlongdan' Download PDF

Info

Publication number
CN1293990A
CN1293990A CN 99115605 CN99115605A CN1293990A CN 1293990 A CN1293990 A CN 1293990A CN 99115605 CN99115605 CN 99115605 CN 99115605 A CN99115605 A CN 99115605A CN 1293990 A CN1293990 A CN 1293990A
Authority
CN
China
Prior art keywords
medicine
changlongdan
radix
rhizoma acori
acori graminei
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 99115605
Other languages
Chinese (zh)
Inventor
周小青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan University of Chinese Medicine
Original Assignee
Hunan University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan University of Chinese Medicine filed Critical Hunan University of Chinese Medicine
Priority to CN 99115605 priority Critical patent/CN1293990A/en
Publication of CN1293990A publication Critical patent/CN1293990A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine in the form of capsules for treating senile dementia is prepared from 8 Chinese-medicinal materials including grass-leaved sweetflag rhizome, earthworm, epimedium, dodder seed, etc through polverizing notoginseng, distilling out volatile oil from grass-leaved sweetflag rhizome, alcohol extraction of red sage root and polygala root, mixing others with dregs of grass-leaved sweetflag rhizome, decocting, filter, concentrating, mixing, granulating and loading in capsules. Its advantages is no obvious toxin.

Description

Medicine ' Changlongdan '
The present invention relates to a kind of Chinese patent medicine, is a kind of Chinese patent medicine for the treatment of senile dementia.
The old people is because dementia is easily suffered from the influence of naturally-aged and pathological factor, and effective control of senile dementia is the difficult problem of present geriatrics and spiritual neuromedicine.Mostly the western medical treatment that this is sick is the psychostimulant of application cerebral vasodilator, brain metabolism improving medicine, nootropics, calcium antagonist and medium action intensity etc.But uncertain therapeutic efficacy is cut, and side effect is bigger, and costs an arm and a leg.The traditional Chinese medical science thinks that function day by day fails, and makes easily clearly that key is subjected to cover, sudden inspiration is slow-witted blunt, deficiency of kidney-essence is not enough for morbidity this, and expectorant stasis of blood resistance key is morbific key.Existing Chinese medicine prevention senile dementia, how from the kidney invigorating, eliminate the phlegm or the treatment aspect medication of blood stasis dispelling but simple tonify deficiency, eliminating evil, always unsatisfactory curative effect.
Purpose of the present invention is to provide a kind of Chinese medicine medicine ' Changlongdan ' for the treatment of both the principal and secondary aspects of a disease from aspects such as kidney tonifying, essence replenishing benefit marrow, blood circulation promoting and blood stasis dispelling, waking up the patient from unconsciousness by dissipating phlegm, refreshment Fructus Alpiniae Oxyphyllaes.
One pair of prescriptions of Chinese medicine of the present invention is: Rhizoma Acori Graminei 10g, Pheretima 3g, Herba Epimedii 10g, Semen Cuscutae 10g, Fructus Lycii 10g, Typhonium flagelliforme (Lodd.) Blume 15g, Radix Polygalae 10g, Radix Salviae Miltiorrhizae 15g.
Preparation technology of the present invention is: A, Radix Notoginseng are pulverized and are fine powder; B, Rhizoma Acori Graminei distill out volatile oil, use beta-cyclodextrin inclusion compound; C, Radix Salviae Miltiorrhizae and Radix Polygalae reclaim ethanol with ethanol extraction, concentrate alcohol extract; D, Herba Epimedii, Semen Cuscutae, Pheretima, Fructus Lycii and Rhizoma Acori Graminei medicinal residues merge, and carry with decocting, and the aqueous extract slagging-off concentrates.With C, D two concentrated solution mixings, drying, be ground into fine powder, merge mixing, granulation, filler capsule with A, B again, promptly get medicine ' Changlongdan ' of the present invention.
Herba Epimedii, Fructus Lycii, Semen Cuscutae have the effect of kidney tonifying, essence replenishing benefit marrow among the present invention; The effect of Radix Notoginseng, Pheretima, Radix Salviae Miltiorrhizae tool blood circulation promoting and blood stasis dispelling, tonneau meridians; Rhizoma Acori Graminei, Radix Polygalae, but mind tranquilizing and the heart calming, waking up the patient from unconsciousness by dissipating phlegm, refreshment Fructus Alpiniae Oxyphyllae.All medicines share, and can nurse one's health effectively and shield and sustain essence, marrow, god, and looking the heart, brain, kidney is one, treating both the principal and secondary aspects of a disease.The present invention has that stripping is rapid, bioavailability is better and stay-in-grade characteristics, is convenient to take for a long time.
The long-term toxicity test for animals result of medicine ' Changlongdan ': rat was taken medicine for 13 weeks continuously, and general behavior, appetite, drinking-water etc. all do not have obviously influence.Hematological examination is the result show, behind oral this medicine erythrocyte, leukocyte, hemoglobin, platelet, clotting time etc. do not had obviously influence.System's pathologic finding does not have the obvious damage effect to each internal organs.Left alone without help medicine is done above inspection, all no abnormal change after two weeks.
Clinical efficacy: produce effects 6 examples, effective 31 examples, invalid 5 examples, total effective rate 88. 1%.

Claims (2)

1, a kind of oral Chinese patent medicine medicine ' Changlongdan ', the prescription of one pair of medicine ' Changlongdan ' is: Rhizoma Acori Graminei 10g, Pheretima 3g, Herba Epimedii 10g, Semen Cuscutae 10g, Fructus Lycii 10g, Typhonium flagelliforme (Lodd.) Blume 15g, Radix Polygalae 10g, Radix Salviae Miltiorrhizae 15g.
2, the preparation technology of medicine ' Changlongdan ' is: A, Radix Notoginseng are pulverized and are fine powder; B, Rhizoma Acori Graminei distill out volatile oil, use beta-cyclodextrin inclusion compound; C, Radix Salviae Miltiorrhizae and Radix Polygalae reclaim ethanol with ethanol extraction, concentrate alcohol extract; D, Herba Epimedii, Semen Cuscutae, Pheretima, Fructus Lycii and Rhizoma Acori Graminei medicinal residues merge, and carry with decocting, and the aqueous extract slagging-off concentrates; With C, D two concentrated solution mixings, drying, be ground into fine powder, merge mixing, granulation, filler capsule with A, B again, promptly get medicine ' Changlongdan ' of the present invention.
CN 99115605 1999-10-25 1999-10-25 Medicine 'Changlongdan' Pending CN1293990A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 99115605 CN1293990A (en) 1999-10-25 1999-10-25 Medicine 'Changlongdan'

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 99115605 CN1293990A (en) 1999-10-25 1999-10-25 Medicine 'Changlongdan'

Publications (1)

Publication Number Publication Date
CN1293990A true CN1293990A (en) 2001-05-09

Family

ID=5278540

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 99115605 Pending CN1293990A (en) 1999-10-25 1999-10-25 Medicine 'Changlongdan'

Country Status (1)

Country Link
CN (1) CN1293990A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100462095C (en) * 2003-09-04 2009-02-18 深圳万基药业有限公司 Brain and intellectual health care medicine and its preparation
CN104173637A (en) * 2014-08-05 2014-12-03 湖南中医药大学 Traditional Chinese medicine composition for treating gerontic vascular dementia and preparation method thereof
CN107022406A (en) * 2017-03-24 2017-08-08 合肥云都棉花有限公司 A kind of tonifying kidneys and nourishing brain cottonseed oil

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100462095C (en) * 2003-09-04 2009-02-18 深圳万基药业有限公司 Brain and intellectual health care medicine and its preparation
CN104173637A (en) * 2014-08-05 2014-12-03 湖南中医药大学 Traditional Chinese medicine composition for treating gerontic vascular dementia and preparation method thereof
CN104173637B (en) * 2014-08-05 2018-02-27 湖南中医药大学 A kind of Chinese medicine composition for treating senile vascular dementia and preparation method thereof
CN107022406A (en) * 2017-03-24 2017-08-08 合肥云都棉花有限公司 A kind of tonifying kidneys and nourishing brain cottonseed oil

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN101690764B (en) Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof
CN103990081A (en) Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice
CN1524542A (en) Medicament for treating acute and chronic rhinitis and nasosinusitis
CN1112836A (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN1486740A (en) Chinese medicine composition for treating cancer
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN1557373A (en) Chinese medicine preparation for treating climacteric metancholia of liver depression and qi stagnation
CN114767824B (en) Preparation for treating laryngeal cough and preparation method thereof
CN103550688B (en) A kind of Chinese medicine composition for the treatment of cardiopalmus
CN1293990A (en) Medicine 'Changlongdan'
CN104958429A (en) Traditional Chinese medicinal composition for treating geriatric fracture and preparation method thereof
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN106668328A (en) Plant composing prescription for treating CP (chronic prostatitis) and preparation method of plant composing prescription
CN102283972B (en) Pharmaceutical composition for treating rib fracture
CN101850071A (en) Chinese medicament for treating chronic nephritis
CN101278982A (en) Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same
CN104758652A (en) Traditional Chinese medicine composition for treating dizziness
CN1907345A (en) Chinese traditional medicine composition for treating cerebral apoplexy
CN1272047C (en) Medicine for invigorating liver and kidney to treat dryness of large intestine and constipation
CN1102574A (en) Rhinitis medicine
CN108066681A (en) It is a kind of for mongolian medicine patch of infantile hyperpyrexia and preparation method thereof and application method
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN1201811C (en) Chinese medicine composition for treating myopia and preparing method thereof
CN113908208B (en) Liver-protecting pharmaceutical composition and preparation method and application thereof

Legal Events

Date Code Title Description
BB1A Publication of application
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication